Newcastle Disease, Infectious Bronchitis, Avian Influenza (H9 Subtype) and Infectious Bursal Disease Vaccine, Inactivated
- Indication / Application: Used for the prevention of Newcastle Disease(La Sota+A-VII), Infectious Bronchitis virus strain QX，Avian Influenza (H9N2 subtype clade 4.1.a and 4.1.b) and Infectious Bursal Disease Virus.
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Newcastle Disease, Infectious Bronchitis, Avian Influenza (H9 Subtype) and Infectious Bursal Disease Vaccine, Inactivated
Composition and Content
| Disease | Strain/Serotype | Antigen Content | Optional Strain(s) |
|---|---|---|---|
| ND | La Sota | ≥ 108.5 EID50/0.1ml | La Sota + A-VII |
| IB | M41 | ≥ 106.5 EID50/0.1ml | QX; M41 + QX |
| AI(H9N2) | Clade 9.4.2.5 | ≥ 108.5 EID50/0.1ml | H9 (9.4.1a); H9 (9.4.1b) |
| IBD | B87 + rVP2 | B87 ≥ 106.5 TCID50/dose |
CA; CF (W252); rVP2 (cIBDV; varIBDV; vvIBDV; nVarIBDV) |
| rVP2: AGP ≥ 1:8/dose |
Indications
For the prevention of Newcastle disease (La Sota strain), infectious bronchitis (M41 strain), avian influenza (H9N2 subtype, clade 9.4.2.5), and infectious bursal disease. Immunity develops 14-21 days after vaccination and lasts for 3 months in chicks and 6 months in adult chickens.
Dosage and Administration
Administer subcutaneously in the neck or intramuscularly: 0.3 mL per bird for chickens under 3 weeks of age; 0.5 mL per bird for chickens over 3 weeks of age.
Adverse Reactions
Generally, no adverse reactions occur.
Specification
250 mL/bottle; 500 mL/bottle.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
A uniform milky-white emulsion.
Precautions
- 1. Vaccinate healthy chickens only. Do not use in emaciated or sick chickens.
- 2. Before use, check for vial damage, a missing label, visible foreign matter, or severe oil-water separation. Discard if any abnormality is found.
- 3. Use within 2 hours after first opening and avoid contamination.
- 4. Do not freeze.
- 5. Sterilize needles and syringes by autoclaving or boiling.
- 6. May be used with live Newcastle disease and infectious bronchitis vaccines to enhance cellular and mucosal immunity.
1. Dual-Strain Broad Protection
- 1. One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.
- 2. Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.
- 3. Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.
- 4. The vaccine contains composite antigens from classical very virulent Infectious Bursal Disease virus (cvvIBDV) and novel variant IBDV (nvIBDV), offering improved cross-protection against both strains as an upgraded version of the company’s original inactivated IBD vaccine series.
- 5. The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.